Authors
Loading...
Analysis of relapse-free survival in NPM1-mutated AML patients shows important prognostic factors, implying a need for tailored therapies.
Yu et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: